Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JINS HoldingsFRA:5F3 -19.61%96 Gross Margin % is 78.41% as of Feb. 2026, which is 2% above its 10-year median of 77.15. GuruFocus rates FRA:5F3 with a GF Score™ of 96/100 and a GF Value™ of €36.43. Among 807 Medical Devices & Instruments companies, JINS Holdings ranks better than 90.21% on this metric.
The historical rank and industry rank for JINS Holdings's Gross Margin % or its related term are showing as below:
FRA:5F3'
s Gross Margin % Range Over the Past 10 Years
Min: 74.75 Med: 77.15 Max: 78.89
Current: 78.36
During the past 13 years, the highestGross Margin % of JINS Holdings was 78.89%. The lowest was 74.75%. And the median was 77.15%.
FRA:5F3's Gross Margin % is ranked better than 90.21% of 807
companies
in the Medical Devices & Instruments industry
Industry Median: 52.03
vs FRA:5F3: 78.36
JINS Holdings had a gross margin of 78.41% for the quarter that ended in Feb. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for JINS Holdings was -0.10% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
JINS Holdings had a gross margin of 78.41% for the quarter that ended in Feb. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
JINS Holdings Gross Margin % Related Terms
JINS Holdings Gross Margin % Historical Data
* Premium members only.
The historical data trend for JINS Holdings's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:5F3 vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, JINS Holdings's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JINS Holdings Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JINS Holdings's Gross Margin % distribution charts can be found below:
* The bar in red indicates where JINS Holdings's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
JINS Holdings (FRA:5F3) has a Gross Margin % of 78.41% as of Feb. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on JINS Holdings and its competitors. This is near median its historical median of 77.15. Over the past decade, JINS Holdings' Gross Margin % has ranged from 74.75 to 78.89. According to the industry distribution chart, JINS Holdings ranks #79 out of 807 companies in the Medical Devices & Instruments industry, placing it in the top 9.8%.
Is JINS Holdings' Gross Margin % too high?
JINS Holdings' current Gross Margin % of 78.41% is near median its 10-year median of 77.15. Over the past 10 years, this metric has ranged from a low of 74.75 to a high of 78.89. The Medical Devices & Instruments industry median Gross Margin % is 52.03. JINS Holdings' value of 78.41% is 50.7% above this industry median. Based on the distribution chart, JINS Holdings ranks #79 out of 807 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, JINS Holdings has a GF Score™ of 96/100, reflecting its overall financial health beyond just this single metric.
How does JINS Holdings' Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JINS Holdings ranks #79 out of 807 companies for Gross Margin %. This places JINS Holdings in the top 10% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 52.03. JINS Holdings' value of 78.41% is 50.7% above this benchmark. Historically, JINS Holdings' own Gross Margin % has ranged from 74.75 to 78.89 over the past decade. While the company's 10-year median is 77.15 vs. the industry median of 52.03, JINS Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.03, based on 807 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. JINS Holdings's current Gross Margin % of 78.41% is 50.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on JINS Holdings and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.03 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JINS Holdings's current Gross Margin % is 78.41%, which is near median its own 10-year median of 77.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JINS Holdings stock overvalued right now?
JINS Holdings (FRA:5F3) has a current Gross Margin % of 78.41%. The stock's GF Value™ is €36.43, compared to a current price of €32.80 — trading 10% below its estimated fair value. The current Gross Margin % is 78.41%, which is near median its 10-year median of 77.15 and 50.7% above the Medical Devices & Instruments industry median of 52.03. JINS Holdings' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For JINS Holdings (FRA:5F3), the current Gross Margin % is 78.41% as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JINS Holdings (FRA:5F3) Overvalued in 2026?
Based on GuruFocus' analysis, JINS Holdings stock appears to be undervalued.
The current stock price of €32.80 is trading 10% below its estimated GF Value™ of €36.43.
Key valuation signals for FRA:5F3:
Gross Margin %: 78.41% (near median its 10-year median of 77.15)
GF Value™: €36.43 vs. price of €32.80 (10% below fair value)
Industry Position: 50.7% above the Medical Devices & Instruments median (#79 of 807)
No single metric tells the full story. See the FRA:5F3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JINS Holdings Inc is an eyewear retailer that manufactures and sells private-label fashion eyeglasses and sunglasses. It offers prescription eyeglasses and nonprescription fashion or functional eyeglasses. Its inventory is on the shelves, and it charges flat rates with generally no additional charges or options for lens features. Jin has more than 300 stores in Japan as well as locations in China, Taiwan, and the United States. Stores are typically located in high-traffic areas such as shopping centers, malls, and train stations.
96GF Score
Get the complete analysis for FRA:5F3
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:5F3 has been successfully added to your 
